| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 270 | 2019 |
| Relation of lipoprotein (a) levels to incident type 2 diabetes and modification by alirocumab treatment GG Schwartz, M Szarek, VA Bittner, DL Bhatt, R Diaz, SG Goodman, ... Diabetes Care 44 (5), 1219-1227, 2021 | 27 | 2021 |
| PROGNOSTICATION OF CLINICAL OUTCOMES AFTER STEMI: THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-A. O Petyunina, M Kopytsya, I Kuznetsov, I Vyshnevska Georgian medical news, 79-86, 2018 | 7 | 2018 |
| Removal of the tumor thrombus from the right atrium without extracorporeal circulation: Emphasis on the displacement of the tumor apex DV Shchukin, VN Lesovoy, GG Khareba, AI Harahatyi, AV Maltsev, ... Advances in Urology 2020 (1), 6063018, 2020 | 6 | 2020 |
| Lower circulating cell-free mitochondrial DNA is associated with heart failure in type 2 diabetes mellitus patients TA Berezina, MP Kopytsya, OV Petyunina, AA Berezin, Z Obradovic, ... Cardiogenetics 13 (1), 15-30, 2023 | 5 | 2023 |
| The vascular endothelial growth factor-A gene polymorphism predicts clinical outcomes among acute ST-segment elevation myocardial infarction patient IM Kutia, MP Kopytsya, YV Hilova, OV Petyunina, AE Berezin | 5 | 2020 |
| Biomarker-based prognostication of adverse cardiac remodeling after STEMI: the role of single nucleotide polymorphism T786C in endothelial NO-synthase gene OV Petyunina, MP Kopytsya, AE Berezin Journal of Cardiology and Therapy 6 (1), 768-774, 2019 | 5 | 2019 |
| Biomarker SST2 as an early predictor of acute renal injury in patients with ST-segment elevation acute myocardial infarction. I Vyshnevska, M Kopytsya, Y Hilоva, E Protsenko, O Petyunina Georgian Medical News, 53-58, 2020 | 4 | 2020 |
| Short-term clinical outcomes in patients with acute myocardial infarction after successful percutaneous coronary revascularization: the role of promoter polymorphism of the … OV Petyunina, MP Kopytsya, DP Babichev, AE Berezin Biomedical Research and Therapy 6 (5), 3166-3179, 2019 | 4 | 2019 |
| Promising Role of Vascular Endothelial Growth Factor-A in Risk Stratification after PCI OV Petyunina, MP Kopytsya, IS Rudyk, GS Isayeva Vascular Access Surgery-Tips and Tricks, 2019 | 4 | 2019 |
| Macrophage inhibitory factor predicted late cardiac remodeling in acute myocardial infarction patients underwent successful percutaneous coronary intervention OV Petyunina, MP Kopytsya, AE Berezin La Prensa Medica Argentina 105 (5), 160-169, 2019 | 4 | 2019 |
| Features of the cardiovascular system lesion in patients with COVID-19 M Kopytsya, I Rodionova, N Tytarenko, Y Hilyova, I Kutya, A Kobets ScienceRise: Medical Science, 4-12, 2020 | 3 | 2020 |
| Elevated levels of circulating soluble ST2 at discharge predict late adverse ventricular remodeling in patients with ST-segment elevation myocardial infarction OV Petyunina, MP Kopytsya, AE Berezin Biomedical Research and Therapy 5 (12), 2863-2875, 2018 | 3 | 2018 |
| GROWTH DIFFERENTIATION FACTOR 15 AS A PROGNOSTIC MARKER OF CHRONIC HEART FAILURE PROGRESSION IN LONG-TERM FOLLOW-UP AFTER ACUTE CORONARY SYNDROME. M Kopytsya, I Vyshnevska, O Protsenko, H Barahmeh Georgian Medical News, 61-66, 2017 | 3 | 2017 |
| The role of biomarker macrophage migration inhibitory factor in cardiac remodeling prediction in patients with st-segment elevation myocardial infarction IR Vyshnevska, T Storozhenko, MP Kopytsya, NV Bila, A Kis, M Kaaki Wiad Lek 76, 911-9, 2023 | 2 | 2023 |
| Macrophage migration inhibitory factor levels predict no-reflow in ST-segment elevation myocardial infarction TY Storozhenko, IR Vishnevskaya, MP Kopytsya, AE Berezin | 2 | 2021 |
| The role of growth differentiation factor 15 as a predictor of 5-year survival of patients after acute coronary syndrome. IR Vyshnevska, MP Kopytsya, IM Kutya, OS Protsenko Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 48 (287 …, 2020 | 2 | 2020 |
| Особенности поражения сердечно-сосудистой системы при COVID-19 НП Копица, ЮВ Родионова, НВ Титаренко, ЯВ Гилёва, ИН Кутя, ... Science Rise: Medical Science 3 (36), 4-12, 2020 | 2 | 2020 |
| The role of Val66Met single nucleotide polymorphism in brain-derived neurotropic factor gene in prediction of adverse outcomes after ST-segment elevation myocardial infarction OV Petyunina, MP Kopytsya, AE Berezin, OV Skrynnyk Heart and Mind 3 (1), 7-14, 2019 | 2 | 2019 |
| Васкулоендотеліальний фактор росту А та поліморфізм G634C гена ВЕФР-A у хворих інфарктом міокарда в гострий та віддалений періоди МП Копиця, ІМ Кутя, ЮВ Родіонова World science 2 (8 (36)), 11-17, 2018 | 2 | 2018 |
